Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels.

Source:http://linkedlifedata.com/resource/pubmed/id/21363929

Download in:

View as

General Info

PMID
21363929